(Q41788543)

9 October 2017

In vitro antibacterial activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457. (English)

1 reference

9 October 2017

4

Robert K Flamm

1 reference

9 October 2017

Barbara D Foleno

1

1 reference

9 October 2017

Darren Abbanat

2

1 reference

9 October 2017

Raul M Goldschmidt

3

1 reference

9 October 2017

Steve D Paget

5

1 reference

9 October 2017

Glenda C Webb

6

1 reference

9 October 2017

Ellyn Wira

7

1 reference

9 October 2017

Mark J Macielag

8

1 reference

9 October 2017

Karen Bush

9

1 reference

9 October 2017

language of work or name

English

0 references

publication date

13 November 2006

1 reference

Antimicrobial Agents and Chemotherapy

9 October 2017

1 reference

9 October 2017

51

1 reference

9 October 2017

1

1 reference

9 October 2017

361-365

1 reference

The emergence of infections with community-associated methicillin resistant Staphylococcus aureus

9 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797661

Update on linezolid: the first oxazolidinone antibiotic

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797661

Hidden epidemic of macrolide-resistant pneumococci

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797661

Antibacterial drug discovery in the 21st century

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797661

Antimicrobial resistance among gram-positive organisms in the intensive care unit

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797661

Oxazolidinone Structure–Activity Relationships Leading to Linezolid

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797661

Linezolid in vitro: mechanism and antibacterial spectrum

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797661

Cross-linking in the Living Cell Locates the Site of Action of Oxazolidinone Antibiotics

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797661

Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797661

In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797661

In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797661

6 June 2018

Identifiers

DOI

10.1128/AAC.01017-06

1 reference

9 October 2017

1 reference

9 October 2017

PubMed publication ID

17101672

1 reference